Yun HD - Search Results

1

Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital.

Yun HD, Dossul T, Bernal-Mizrachi L, Switchenko J, Ndibe C, Ibraheem A, Dixon MD, Langston AA, Nooka AK, Flowers CR, Pentz RD, Waller EK. Yun HD, et al. J Stem Cell Res Ther. 2016;6:328. doi: 10.4172/2157-7633.1000328. Epub 2016 Feb 19. J Stem Cell Res Ther. 2016. PMID: 28966870 Free PMC article.

2

Finding the sweet spot for donor lymphocyte infusions.

Yun HD, Waller EK. Yun HD, et al. Biol Blood Marrow Transplant. 2013 Apr;19(4):507-8. doi: 10.1016/j.bbmt.2013.02.005. Epub 2013 Feb 14. Biol Blood Marrow Transplant. 2013. PMID: 23416853 Free article. No abstract available.

3

Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia.

Yun HD, Waller EK. Yun HD, et al. Blood. 2013 Jul 25;122(4):474. doi: 10.1182/blood-2013-02-481697. Blood. 2013. PMID: 24049774 Free article. No abstract available.

4

Clinical Relevance of Immunobiology in Umbilical Cord Blood Transplantation.

Yun HD, Varma A, Hussain MJ, Nathan S, Brunstein C. Yun HD, et al. J Clin Med. 2019 Nov 14;8(11):1968. doi: 10.3390/jcm8111968. J Clin Med. 2019. PMID: 31739455 Free PMC article. Review.

5

Evolution of clonal dynamics and differential response to targeted therapy in a case of systemic mastocytosis with associated myelodysplastic syndrome.

Yun HD, Antony ML, Linden MA, Noble-Orcutt KE, Eckfeldt CE, Ustun C, Nelson AC, Sachs Z. Yun HD, et al. Leuk Res. 2020 Aug;95:106404. doi: 10.1016/j.leukres.2020.106404. Epub 2020 Jun 11. Leuk Res. 2020. PMID: 32569927 Free PMC article.

6

Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia.

Yun HD, Schirm DK, Felices M, Miller JS, Eckfeldt CE. Yun HD, et al. Blood Adv. 2019 Aug 27;3(16):2448-2452. doi: 10.1182/bloodadvances.2019000064. Blood Adv. 2019. PMID: 31416822 Free PMC article.

7

DLBCL After Allogeneic HCT in a Patient With Transformed DLBCL: Does It Matter Whether Relapse or PTLD?

Nathan S, Hussain MJ, Baptista J, Yun HD, Varma A, Vardouniotis A, Weber M, Miller I, Ustun C. Nathan S, et al. Among authors: yun hd. Clin Lymphoma Myeloma Leuk. 2020 Apr;20(4):264-266. doi: 10.1016/j.clml.2019.12.002. Epub 2019 Dec 23. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32115402 No abstract available.

8

Erythroid differentiation of myeloblast induced by gilteritinib in relapsed FLT3-ITD-positive acute myeloid leukemia.

Yun HD, Nathan S, Larson M, Hussain MJ, Katz DA, Varma A, Miller I, Ustun C. Yun HD, et al. Blood Adv. 2019 Nov 26;3(22):3709-3712. doi: 10.1182/bloodadvances.2019000775. Blood Adv. 2019. PMID: 31765477 Free PMC article. No abstract available.

9

Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells.

Yun HD, Felices M, Vallera DA, Hinderlie P, Cooley S, Arock M, Gotlib J, Ustun C, Miller JS. Yun HD, et al. Blood Adv. 2018 Jul 10;2(13):1580-1584. doi: 10.1182/bloodadvances.2018018176. Blood Adv. 2018. PMID: 29980573 Free PMC article.

10

Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.

Zeidan AM, Ricklis RM, Carraway HE, Yun HD, Greer JM, Smith BD, Levis MJ, McDevitt MA, Pratz KW, Showel MM, Gladstone DE, Gore SD, Karp JE. Zeidan AM, et al. Among authors: yun hd. Br J Haematol. 2012 Jul;158(2):198-207. doi: 10.1111/j.1365-2141.2012.09142.x. Epub 2012 May 18. Br J Haematol. 2012. PMID: 22594769 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page